Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Neumann

Showing results (631-640 of 650) with videos related to

Pageof 65
Sort By:
Endocrine-Related Cancer|January 18, 2015
A registry-based study of thyroid paraganglioma: histological and genetic characteristicsErnst von Dobschuetz, Helena Leijon, Camilla Schalin-Jäntti, et al.
JAMA|October 27, 2005
Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC geneFrancesca Schiavi, Carsten C Boedeker, Birke Bausch, et al.
The New England Journal of Medicine|May 10, 2002
Germ-line mutations in nonsyndromic pheochromocytomaHartmut P H Neumann, Birke Bausch, Sarah R McWhinney, et al.
Head & Neck|April 14, 2015
Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the International Endolymphatic Sac Tumor RegistryBirke Bausch, Ulrich Wellner, Mathieu Peyre, et al.
Aerobiologia|April 20, 2026
Five years of national airborne pollen monitoring in South Africa: biome-specific calendars to inform allergy diagnosis and preventionTakudzwa Matuvhunye, Dilys M Berman, Nanike Esterhuizen, et al.
Endocrine-Related Cancer|July 28, 2010
Systematic comparison of sporadic and syndromic pancreatic islet cell tumorsZoran Erlic, Ursula Ploeckinger, Alberto Cascon, et al.
Endocrine Connections|May 7, 2020
Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter studyLouise Vølund Larsen, Delphine Mirebeau-Prunier, Tsuneo Imai, et al.
Endocrine-Related Cancer|June 27, 2017
The penetrance of MEN2 pheochromocytoma is not only determined by <i>RET</i> mutationsFrederic Castinetti, Ana Luiza Maia, Mariola Peczkowska, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2007
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1Birke Bausch, Wiktor Borozdin, Victor F Mautner, et al.
JAMA Oncology|April 7, 2017
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed PreventionBirke Bausch, Francesca Schiavi, Ying Ni, et al.
Pageof 65

Showing results (631-640 of 650) with videos related to

Sort By:
Pageof 65
Endocrine-Related Cancer|January 18, 2015
A registry-based study of thyroid paraganglioma: histological and genetic characteristicsErnst von Dobschuetz, Helena Leijon, Camilla Schalin-Jäntti, et al.
JAMA|October 27, 2005
Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC geneFrancesca Schiavi, Carsten C Boedeker, Birke Bausch, et al.
The New England Journal of Medicine|May 10, 2002
Germ-line mutations in nonsyndromic pheochromocytomaHartmut P H Neumann, Birke Bausch, Sarah R McWhinney, et al.
Head & Neck|April 14, 2015
Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the International Endolymphatic Sac Tumor RegistryBirke Bausch, Ulrich Wellner, Mathieu Peyre, et al.
Aerobiologia|April 20, 2026
Five years of national airborne pollen monitoring in South Africa: biome-specific calendars to inform allergy diagnosis and preventionTakudzwa Matuvhunye, Dilys M Berman, Nanike Esterhuizen, et al.
Endocrine-Related Cancer|July 28, 2010
Systematic comparison of sporadic and syndromic pancreatic islet cell tumorsZoran Erlic, Ursula Ploeckinger, Alberto Cascon, et al.
Endocrine Connections|May 7, 2020
Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter studyLouise Vølund Larsen, Delphine Mirebeau-Prunier, Tsuneo Imai, et al.
Endocrine-Related Cancer|June 27, 2017
The penetrance of MEN2 pheochromocytoma is not only determined by <i>RET</i> mutationsFrederic Castinetti, Ana Luiza Maia, Mariola Peczkowska, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2007
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1Birke Bausch, Wiktor Borozdin, Victor F Mautner, et al.
JAMA Oncology|April 7, 2017
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed PreventionBirke Bausch, Francesca Schiavi, Ying Ni, et al.
Pageof 65